Engineered antibody helps block SARS-CoV-2 transmission
Researchers at UC Davis Health have engineered a novel antibody, FuG1, that can directly interfere with the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19.
Researchers at UC Davis Health have engineered a novel antibody, FuG1, that can directly interfere with the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19.
Cell & Microbiology
Feb 11, 2022
0
63
It is widely understood that antibodies neutralize viruses by latching onto their surfaces and blocking them from infecting host cells. But new research reveals that this barrier method isn't the only way that antibodies ...
Cell & Microbiology
Nov 30, 2021
0
606
A multi-institutional team led by researchers at Vanderbilt University Medical Center has isolated monoclonal antibodies that in laboratory and animal studies prevented infection by alphaviruses, including the often-lethal ...
Cell & Microbiology
Aug 20, 2021
0
260
As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions ...
Cell & Microbiology
Jul 23, 2021
1
595
When harmful bacteria or viruses enter the body, immune cells spot telltale proteins known as antigens on the invaders' surfaces and send out armies of antibodies to fend them off. If some of those antibodies have just the ...
Biochemistry
Jun 28, 2021
0
34
In the course of a new and groundbreaking study, led by Dr. Natalia Freund and the doctoral candidate Avia Watson at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered ...
Cell & Microbiology
Feb 22, 2021
0
43
Editor's note: In this interview, Nathan Ahlgren, assistant professor of biology at Clark University, uses 3-D-printed models to explain what proteins do in viruses, how they interact with human cells, how the vaccine delivers ...
Cell & Microbiology
Jan 26, 2021
0
4
An antibody that can stop the new coronavirus infecting cells in laboratory tests has been identified by researchers in the Netherlands, in what scientists say could help the development of therapies for COVID-19.
Cell & Microbiology
May 5, 2020
0
17
Synthetic antibodies constructed using bacterial superglue can neutralise potentially lethal viruses, according to a study published on April 21 in eLife.
Cell & Microbiology
Apr 28, 2020
1
685
Despite efforts to contain it, bird flu remains a serious menace to public health.
Cell & Microbiology
Dec 16, 2019
0
35